Results 21 to 30 of about 1,487,644 (266)

The blood–brain barrier: Structure, regulation and drug delivery

open access: yesSignal Transduction and Targeted Therapy, 2023
Blood–brain barrier (BBB) is a natural protective membrane that prevents central nervous system (CNS) from toxins and pathogens in blood. However, the presence of BBB complicates the pharmacotherapy for CNS disorders as the most chemical drugs and ...
Di Wu   +5 more
semanticscholar   +1 more source

Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy

open access: yesPharmaceutics, 2023
Targeted drug delivery is a precise and effective strategy in oncotherapy that can accurately deliver drugs to tumor cells or tissues to enhance their therapeutic effect and, meanwhile, weaken their undesirable side effects on normal cells or tissues. In
Jian-Min Li   +7 more
semanticscholar   +1 more source

Oleyl Conjugated Histidine-Arginine Cell-Penetrating Peptides as Promising Agents for siRNA Delivery

open access: yesPharmaceutics, 2022
Recent approvals of siRNA-based products motivated the scientific community to explore siRNA as a treatment option for several intractable ailments, especially cancer.
Muhammad Imran Sajid   +5 more
doaj   +1 more source

Nanoparticles and convergence of artificial intelligence for targeted drug delivery for cancer therapy: Current progress and challenges

open access: yesFrontiers in Medical Technology, 2023
Cancer is a life-threatening disease, resulting in nearly 10 million deaths worldwide. There are various causes of cancer, and the prognostic information varies in each patient because of unique molecular signatures in the human body.
Kalpataru Das, C. J
semanticscholar   +1 more source

Functionalized liposomes for targeted breast cancer drug delivery

open access: yesBioactive Materials, 2023
Despite the exceptional progress in breast cancer pathogenesis, prognosis, diagnosis, and treatment strategies, it remains a prominent cause of female mortality worldwide.
Janske Nel   +8 more
semanticscholar   +1 more source

Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovarian Cancer Cell Lines

open access: yesPharmaceutics, 2023
RNA interference (RNAi) has drawn enormous attention as a powerful tool because of its capability to interfere with mRNA and protein production. However, designing a safe and efficient delivery system in RNAi therapeutics remains challenging.
Dindyal Mandal   +6 more
doaj   +1 more source

Mitochondrial Dysfunction: Pathophysiology and Mitochondria-Targeted Drug Delivery Approaches

open access: yesPharmaceutics, 2022
Mitochondria are implicated in a wide range of functions apart from ATP generation, and, therefore, constitute one of the most important organelles of cell.
Tanzeel Khan   +7 more
semanticscholar   +1 more source

[(WR)8WKβA]-Doxorubicin Conjugate: A Delivery System to Overcome Multi-Drug Resistance against Doxorubicin

open access: yesCells, 2022
Doxorubicin (Dox) is an anthracycline chemotherapeutic agent used to treat breast, leukemia, and lymphoma malignancies. However, cardiotoxicity and inherent acquired resistance are major drawbacks, limiting its clinical application.
Khalid Zoghebi   +3 more
doaj   +1 more source

The roles of microRNA families in hepatic fibrosis

open access: yesCell & Bioscience, 2017
When hepatocytes are damaged severely, a variety of signaling pathways will be triggered by inflammatory factors and cytokines involving in the process of hepatic fibrosis.
Xue-Ping Jiang   +4 more
doaj   +1 more source

Design, Synthesis, and Antiproliferative Activity of Benzopyran-4-One-Isoxazole Hybrid Compounds

open access: yesMolecules, 2023
The biological significance of benzopyran-4-ones as cytotoxic agents against multi-drug resistant cancer cell lines and isoxazoles as anti-inflammatory agents in cellular assays prompted us to design and synthesize their hybrid compounds and explore ...
Shilpi Gupta   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy